124 related articles for article (PubMed ID: 1411251)
1. Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition.
Eiskjaer H; Bagger JP; Mogensen CE; Schmitz A; Pedersen EB
Scand J Clin Lab Invest; 1992 May; 52(3):193-9. PubMed ID: 1411251
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
[TBL] [Abstract][Full Text] [Related]
3. The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy.
Jansson K; Dahlström U; Karlberg BE; Karlsson E; Nylander E; Nyquist O; Karlberg KE
J Intern Med; 1999 May; 245(5):435-43. PubMed ID: 10363743
[TBL] [Abstract][Full Text] [Related]
4. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.
Vesely DL; Perez-Lamboy GI; Schocken DD
J Card Fail; 2001 Mar; 7(1):55-63. PubMed ID: 11264551
[TBL] [Abstract][Full Text] [Related]
5. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
Lee AF; MacFadyen RJ; Struthers AD
Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
[TBL] [Abstract][Full Text] [Related]
6. Enhanced urinary excretion of albumin and beta 2 microglobulin in essential hypertension induced by atrial natriuretic peptide.
Eiskjaer H; Mogensen CE; Schmitz A; Pedersen EB
Scand J Clin Lab Invest; 1991 Jun; 51(4):359-66. PubMed ID: 1835121
[TBL] [Abstract][Full Text] [Related]
7. Antidiuretic hormone and atrial natriuretic peptide in congestive heart failure.
Fyhrquist F; Tikkanen I
Acta Med Scand Suppl; 1986; 707():55-8. PubMed ID: 2943143
[TBL] [Abstract][Full Text] [Related]
8. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man.
Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Pedersen EB
Int J Cardiol; 1991 Oct; 33(1):61-74. PubMed ID: 1657800
[TBL] [Abstract][Full Text] [Related]
9. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
10. Influence of ramipril on plasma atrial natriuretic peptide, antidiuretic hormone, angiotensin II and aldosterone in patients with chronic congestive heart failure.
Heintz B; Verho M; Brockmeier D; Kirsten R; Nelson K; Rangoonwala B; Maigatter S; Lückel G; Kierdorf H; Sieberth HG
Clin Physiol Biochem; 1992; 9(3):113-8. PubMed ID: 1302161
[TBL] [Abstract][Full Text] [Related]
11. The effect of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man.
McMurray J; Seidelin PH; Howey JE; Balfour DJ; Struthers AD
J Hypertens; 1988 Oct; 6(10):783-6. PubMed ID: 2974052
[TBL] [Abstract][Full Text] [Related]
12. Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease.
Motwani JG; Fenwick MK; Morton JJ; Struthers AD
Am J Cardiol; 1994 Jun; 73(16):1191-6. PubMed ID: 8203337
[TBL] [Abstract][Full Text] [Related]
13. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S
Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
[TBL] [Abstract][Full Text] [Related]
14. [Captopril and hypertensive cardiopathy : therapeutic effects and hormonal changes].
Palazzuoli V; Mondillo S; Galli M; Kristodhullu S; Faglia S; D'Aprile N; Martorelli T
Cardiologia; 1990 Jun; 35(6):489-93. PubMed ID: 2150343
[TBL] [Abstract][Full Text] [Related]
15. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
[TBL] [Abstract][Full Text] [Related]
16. [Effects of captopril on plasma renin activity angiotensin II and aldosterone level in cardiac failure patients].
Qin S; Ma C
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Feb; 19(1):29-31. PubMed ID: 2060462
[No Abstract] [Full Text] [Related]
17. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure.
Dutka DP; Olivotto I; Ward S; Nihoyannopoulos P; al-Subaili M; Oakley CM; Impallomeni M; Cleland JG
Eur Heart J; 1995 Sep; 16(9):1223-30. PubMed ID: 8582385
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
[TBL] [Abstract][Full Text] [Related]
19. Correlation of urinary albumin and beta-2-microglobulin and growth hormone excretion in patients with diabetes mellitus and short stature.
Pan FP; Stevenson JL; Donaldson DL; Levy J; Wiegmann T; Moore WV
J Clin Endocrinol Metab; 1990 Sep; 71(3):611-7. PubMed ID: 2203797
[TBL] [Abstract][Full Text] [Related]
20. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
